FDA's Assessment Of Bisphenol A 'Inadequate': Panel

Law360, New York (October 29, 2008, 12:00 AM EDT) -- A panel advising the U.S. Food and Drug Administration on the safety of bisphenol A says the agency's draft assessment of the controversial chemical was “inadequate” and failed to articulate “reasonable and appropriate” scientific support for the criteria applied to select data for use in the review.

The FDA Science Board Subcommittee on Bisphenol A said in a scientific peer-review released Wednesday that the draft exposure assessment of BPA — a chemical widely used in plastic products — “lacks an adequate characterization of uncertainties in its...
To view the full article, register now.